In a HP experimental model mice treated with CTLA-4Ig showed a significant decrease in the extent of lung damage and in the number of BALF inflammatory cells, with diminished CD4/CD8 T cell ratio. This evidence concerns the gene CD8A and hypersensitivity pneumonitis.